New Study Shows Wide Variation in Telemedicine Use Among Patient Groups

Translate to Spanish or other 102 languages!

Use of telemedicine spiked amid the COVID-19 pandemic, but is still used significantly more in the years following crisis compared to the time before, new analysis from Penn Medicine researchers shows. Image for illustration purposes
Use of telemedicine spiked amid the COVID-19 pandemic, but is still used significantly more in the years following crisis compared to the time before, new analysis from Penn Medicine researchers shows. Image for illustration purposes
- Advertisement -

By Perelman School of Medicine at the University of Pennsylvania

Newswise – Use of telemedicine spiked amid the COVID-19 pandemic, but is still used significantly more in the years following crisis compared to the time before, new analysis from Penn Medicine researchers shows. Telemedicine’s usage varies across patient groups as well, the researchers found. They published their work in the Journal of General Internal Medicine.

Elderly people were more than 50 percent less likely to use telemedicine for their health care visits than going to an office-based appointment. The researchers also found that telemedicine visits were more common in primary care. Those in lower income brackets also more likely (by 6 percent) to make visits via telemedicine than in-office.

- Advertisement -

White patients more likely to use telemedicine, Asian patients 18 percent less likely to use it, Black patients 12 percent less likely, and Hispanic patients 6 percent less likely.

Distance and usage of technology also had a significant bearing on telemedicine usage as well. If a patient was more than 15 miles away from their nearest care provider, they were 42 percent more likely to use telemedicine over in-person care. And if they already used an online patient portal, they were 44 percent more likely to go with telemedicine.

“Telemedicine is no longer just a pandemic workaround—it has become a routine part of care delivery,” said senior author Yong Chen, PhD, a professor of Biostatistics. “The next step is ensuring it can improve access and convenience for all patients, with an eye toward determining and addressing the differences in who is able to use it.”

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

TMA Honors Georgetown Pediatrician for a Career of Distinguished Service 

The Texas Medical Association (TMA) has honored Georgetown pediatrician John W. Hellerstedt, MD, with the 2026 TMA Distinguished Service Award in recognition of his 45 years of exemplary service to patients, public health, and organized medicine.   

FDA Clears Path for Expanded Testosterone Therapy Options for Men

The U.S. Food and Drug Administration is taking an initial step to advance treatment options for men’s health by encouraging sponsors of approved testosterone replacement therapy (TRT) products to contact FDA for information if they are interested in pursuing a potential new indication for low libido in men with idiopathic hypogonadism (without a known cause).

Study Finds Persistent Barriers to Hormone Therapy for Cervical Cancer Patients

Most oncologists say they would prescribe hormone therapy to cervical cancer patients who experience early menopause from radiation treatment, but barriers are keeping many from doing so in practice, according to a new University of Kentucky Markey Cancer Center study published in JAMA Network Open.

STC opens Wellness Center at Health Science Professions Campus

South Texas College recently inaugurated a new Wellness Center at its Health Science Professions Campus in McAllen, giving students, faculty and staff free access to a space designed to support both physical and mental well-being.
- Advertisement -